Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000053

CEO bought 51,200 shares at an average $0.01 ($269)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2019-10-17 Purchase : show line 1 in the form +200 $0.01 $2 25,341,997 D
2019-10-18 Purchase : show line 2 in the form +500 $0.01 $4 25,342,497 D
2019-10-18 Purchase : show line 3 in the form +500 $0.01 $5 25,342,997 D
2019-10-31 Purchase : show line 4 in the form +5,000 $0.00 $24 25,347,997 D
2019-10-31 Purchase : show line 5 in the form +5,000 $0.00 $23 25,352,997 D
2019-10-31 Purchase : show line 6 in the form +5,000 $0.00 $24 25,357,997 D
2019-10-31 Purchase : show line 7 in the form +5,000 $0.00 $22 25,362,997 D
2019-10-31 Purchase : show line 8 in the form +5,000 $0.00 $25 25,367,997 D
Open-market purchases · 51,200 sh · avg $0.01 · $269
Loading xslF345X03/primary_doc.xml…